Cargando…

Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study

Background: The pandemic of coronavirus disease 2019 (COVID-19) resulted in grave morbidity and mortality worldwide. There is currently no effective drug to cure COVID-19. Based on analyses of available data, we deduced that excessive prostaglandin E(2) (PGE(2)) produced by cyclooxygenase-2 was a ke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Wenxin, Chen, Yan, You, Kai, Tan, Shenglin, Wu, Feima, Tao, Jiawang, Chen, Xudan, Zhang, Jiaye, Xiong, Yue, Yuan, Fang, Yang, Zhen, Chen, Tingting, Chen, Xinwen, Peng, Ping, Tai, Qiang, Wang, Jian, Zhang, Fuchun, Li, Yin-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703865/ https://www.ncbi.nlm.nih.gov/pubmed/33312125 http://dx.doi.org/10.3389/fphar.2020.561674

Ejemplares similares

Anaphylaxis to Celebrex during an oral challenge
por: Manga, Vaishaali, et al.
Publicado: (2014)

Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients
por: Ghaznavi, Habib, et al.
Publicado: (2022)

He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study
por: Hu, Haibo, et al.
Publicado: (2021)

Addition of Celebrex and Pregabalin to Ropivacaine for Posterior Spinal Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Zhang, Ye, et al.
Publicado: (2021)

Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
por: Rogers, Elaine S, et al.
Publicado: (2011)

Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
por: Khan, Nabab, et al.
Publicado: (2020)

Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein
por: Wu, Feima, et al.
Publicado: (2021)

Biofunctional roles of estrogen in coronavirus disease 2019: Beyond a steroid hormone
por: Wang, Zhong-Ping, et al.
Publicado: (2022)

Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer
por: Feng, Xing, et al.
Publicado: (2022)

Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer
por: Feng, Xing, et al.
Publicado: (2022)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
por: Andrabi, Mudasir S., et al.
Publicado: (2020)

Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
por: Zuo, Zhihong, et al.
Publicado: (2021)

Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Du, Xu-Qin, et al.
Publicado: (2021)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic
por: Wang, Jia-bo, et al.
Publicado: (2021)

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
por: Chen, Jiande, et al.
Publicado: (2023)

Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study
por: Zhang, Bo, et al.
Publicado: (2020)

Robust expansion and functional maturation of human hepatoblasts by chemical strategy
por: Pan, Tingcai, et al.
Publicado: (2021)

Akt Regulated Phosphorylation of GSK-3β/Cyclin D1, p21 and p27 Contributes to Cell Proliferation Through Cell Cycle Progression From G1 to S/G2M Phase in Low-Dose Arsenite Exposed HaCat Cells
por: Chen, Yao, et al.
Publicado: (2019)

Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
por: Gracia-Hernandez, Maria, et al.
Publicado: (2020)

Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
por: Zhu, Chunsheng, et al.
Publicado: (2020)

Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019
por: Liu, Jingyuan, et al.
Publicado: (2021)

The potential value of exosomes as adjuvants for novel biologic local anesthetics
por: Zhang, Yunmeng, et al.
Publicado: (2023)

Diazepam ameliorated myocardial ischemia-reperfusion injury via inhibition of C-C chemokine receptor type 2/tumor necrosis factor-alpha/interleukins and Bcl-2-associated X protein/caspase-3 pathways in experimental rats
por: JIANG, Tingting, et al.
Publicado: (2021)

Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis–Manifested Severe Disease
por: Cheng, Bin, et al.
Publicado: (2021)

Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit?
por: Lu, Cuicui, et al.
Publicado: (2020)

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Xuewen, et al.
Publicado: (2020)

Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury
por: Zhang, Xinzhu, et al.
Publicado: (2022)

Hepatic DKK1-driven steatosis is CD36 dependent
por: Yang, Zhen, et al.
Publicado: (2022)

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020)

Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis
por: Ma, Lin-Lu, et al.
Publicado: (2020)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
por: Liu, Yangyang, et al.
Publicado: (2022)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
por: Qiu, Qin, et al.
Publicado: (2020)

Regarding: “Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”
por: McCullough, Peter A.
Publicado: (2021)

Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
por: Wang, Heping, et al.
Publicado: (2021)

N-n-butyl Haloperidol Iodide Protects against Hypoxia/Reoxygenation Injury in Cardiac Microvascular Endothelial Cells by Regulating the ROS/MAPK/Egr-1 Pathway
por: Lu, Shishi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tfucn8kch7f53jqogddlsf7fp2